Stocktoria
Cordyceps Sunshine Biotech Holdings Co., Ltd. RAJAF
OTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2023-10-09
Cordyceps Sunshine Biotech Holdings Co., Ltd. financials (annual, from 10-K)
Bars are annual figures from 2021 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.2M | $1.3M | $882,533 | $53,304 | $879,318 |
| Gross profit | $760,741 | $906,480 | $766,387 | $39,558 | -$176,212 |
| R&D expense | — | — | — | $118,444 | $25,052 |
| Operating income | -$141,128 | -$183,913 | $227,833 | -$415,121 | -$119,387 |
| Interest expense | — | — | $26,535 | $71,772 | $12,350 |
| Income tax | — | $34,957 | $21,530 | $792 | $351 |
| Net income | -$154,822 | -$226,258 | $751,609 | -$720,093 | -$491,006 |
| EPS (diluted) | $0.00 | $0.00 | $0.01 | $-0.01 | $0.00 |
| Operating cash flow | -$35,845 | $312,006 | $359,724 | -$394,851 | -$365,363 |
| Free cash flow | — | -$37,231 | $40,237 | -$395,326 | -$465,363 |
| Cash & equivalents | $3,199 | $37,284 | $23,104 | $6,628 | $99,684 |
| Inventory | $674,196 | — | — | $313,530 | $480,352 |
| Total assets | $4.7M | $4.6M | $3.4M | $2.1M | $3.3M |
| Total liabilities | $5.2M | $5.0M | $3.5M | $3.1M | $3.5M |
| Shareholders' equity | -$534,551 | -$375,543 | -$151,796 | -$951,334 | -$275,813 |
Growth · year-over-year · Revenue CAGR 9.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue growth | -0.6% | +42.0% | +1555.7% | -93.9% | — |
| Net income growth | — | -130.1% | — | — | — |
| EPS growth | — | -100.0% | — | — | — |
| Free cash flow growth | — | -192.5% | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001885680 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.